| NCT03382366 |
Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03382366 |
Recruiting |
Istituto Ortopedico Galeazzi |
2019-05-31 |
| NCT04366726 |
Study to Evaluate the PK, PD and Usability of Abaloparatide-sMTS in Postmenopausal Women With Low Bone Mineral Density |
https://ClinicalTrials.gov/show/NCT04366726 |
Completed |
Radius Health, Inc. |
2019-05-14 |
| NCT03367585 |
Effects of Vitamin D Supplementation in Muscle Strength and Balance Training |
https://ClinicalTrials.gov/show/NCT03367585 |
Completed |
University of Sao Paulo General Hospital |
2018-12-01 |
| NCT03091088 |
Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03091088 |
Completed |
University of Valencia |
2013-07-01 |
| NCT03026660 |
Moringa Oleifera on Bone Density |
https://ClinicalTrials.gov/show/NCT03026660 |
Completed |
Appalachian State University |
2016-02-29 |
| NCT02981732 |
CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome |
https://ClinicalTrials.gov/show/NCT02981732 |
Recruiting |
Fujian Academy of Traditional Chinese Medicine |
2019-03-31 |
| NCT02884401 |
Peri-implant Bone Changes in Post-menopausal Osteoporotic Women |
https://ClinicalTrials.gov/show/NCT02884401 |
Recruiting |
Queen Mary University of London |
2021-06-30 |
| NCT02822378 |
Dried Plums and Bone Health in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT02822378 |
Recruiting |
Penn State University |
2021-07-31 |
| NCT02791516 |
A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT02791516 |
Completed |
Amgen |
2018-02-12 |
| NCT02753283 |
Preventing Osteoporosis Using Denosumab |
https://ClinicalTrials.gov/show/NCT02753283 |
Active, not recruiting |
University of Pittsburgh |
2023-09-30 |
| NCT02604836 |
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia |
https://ClinicalTrials.gov/show/NCT02604836 |
Completed |
Hoffmann-La Roche |
2006-04-30 |
| NCT02598934 |
A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT02598934 |
Completed |
Hoffmann-La Roche |
2006-05-31 |
| NCT02598453 |
PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia |
https://ClinicalTrials.gov/show/NCT02598453 |
Completed |
Hoffmann-La Roche |
2006-09-30 |
| NCT02598440 |
A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT02598440 |
Completed |
Hoffmann-La Roche |
2005-05-31 |
| NCT02589600 |
Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) |
https://ClinicalTrials.gov/show/NCT02589600 |
Active, not recruiting |
University of Pittsburgh |
2021-07-31 |
| NCT00089791 |
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00089791 |
Completed |
Amgen |
2008-06-17 |
| NCT02499237 |
Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation |
https://ClinicalTrials.gov/show/NCT02499237 |
Completed |
424 General Military Hospital |
2018-11-30 |
| NCT02478879 |
A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen |
https://ClinicalTrials.gov/show/NCT02478879 |
Completed |
Zosano Pharma Corporation |
2015-11-30 |
| NCT02416947 |
Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women |
https://ClinicalTrials.gov/show/NCT02416947 |
Completed |
Purdue University |
2015-01-31 |
| NCT02247011 |
A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT02247011 |
Completed |
Peking Union Medical College Hospital |
2014-09-30 |
| NCT02176382 |
Denosumab and Teriparatide Study (DATA-HD and DATA-EX) |
https://ClinicalTrials.gov/show/NCT02176382 |
Active, not recruiting |
Massachusetts General Hospital |
2020-01-31 |
| NCT02109042 |
A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants |
https://ClinicalTrials.gov/show/NCT02109042 |
Completed |
Eli Lilly and Company |
2014-07-31 |
| NCT02090400 |
Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT02090400 |
Completed |
Instituto Palacios |
2015-07-31 |
| NCT01292187 |
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT01292187 |
Completed |
Tarsa Therapeutics, Inc. |
2012-05-31 |
| NCT01290094 |
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT01290094 |
Completed |
Hoffmann-La Roche |
2014-07-31 |
| NCT02016716 |
A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT02016716 |
Completed |
Amgen |
2014-09-08 |
| NCT02014467 |
Denosumab China Phase III Study |
https://ClinicalTrials.gov/show/NCT02014467 |
Completed |
GlaxoSmithKline |
2015-08-31 |
| NCT01992159 |
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT01992159 |
Completed |
Amgen |
2014-10-09 |
| NCT01969656 |
Safety Study of an Oral Vitamin D Analog in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01969656 |
Completed |
Deltanoid Pharmaceuticals |
2004-06-30 |
| NCT01881204 |
Hesperidin and Bone Health in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01881204 |
Completed |
Purdue University |
2012-10-31 |
| NCT01796301 |
An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01796301 |
Completed |
Amgen |
2015-05-14 |
| NCT01750086 |
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption |
https://ClinicalTrials.gov/show/NCT01750086 |
Completed |
Massachusetts General Hospital |
2014-04-30 |
| NCT01732770 |
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT01732770 |
Completed |
Amgen |
2015-01-07 |
| NCT01709110 |
VERtebral Fracture Treatment Comparisons in Osteoporotic Women |
https://ClinicalTrials.gov/show/NCT01709110 |
Completed |
Eli Lilly and Company |
2016-07-31 |
| NCT01674621 |
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT01674621 |
Completed |
Radius Health, Inc. |
2013-08-02 |
| NCT01657162 |
Twenty Four Month Extension Study of BA058-05-003 |
https://ClinicalTrials.gov/show/NCT01657162 |
Completed |
Radius Health, Inc. |
2016-10-31 |
| NCT01653275 |
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover |
https://ClinicalTrials.gov/show/NCT01653275 |
Completed |
UConn Health |
2014-12-31 |
| NCT01575834 |
Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT01575834 |
Completed |
Amgen |
2015-12-14 |
| NCT01572545 |
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass |
https://ClinicalTrials.gov/show/NCT01572545 |
Completed |
Aristotle University Of Thessaloniki |
2012-09-30 |
| NCT01571843 |
Radius Loading in Primary Hyperparathyroidism |
https://ClinicalTrials.gov/show/NCT01571843 |
Completed |
Columbia University |
2014-10-31 |
| NCT01544894 |
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT01544894 |
Completed |
University of Valencia |
2011-10-31 |
| NCT01501344 |
Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling |
https://ClinicalTrials.gov/show/NCT01501344 |
Completed |
Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc. |
2011-08-31 |
| NCT01495000 |
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab |
https://ClinicalTrials.gov/show/NCT01495000 |
Completed |
GlaxoSmithKline |
2013-02-28 |
| NCT01457950 |
A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab |
https://ClinicalTrials.gov/show/NCT01457950 |
Completed |
GlaxoSmithKline |
2012-12-31 |
| NCT01350934 |
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) |
https://ClinicalTrials.gov/show/NCT01350934 |
Completed |
Merck Sharp & Dohme Corp. |
2013-01-10 |
| NCT01348243 |
Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT01348243 |
Completed |
Chiesi Farmaceutici S.p.A. |
2013-03-31 |
| NCT01343004 |
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01343004 |
Completed |
Radius Health, Inc. |
2014-10-31 |
| NCT01321723 |
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01321723 |
Completed |
Unigene Laboratories Inc. |
2011-10-31 |
| NCT04321837 |
Coral Calcium’s Effect on Bone Density in Postmenopausal Women With and Without Ibandronate |
https://ClinicalTrials.gov/show/NCT04321837 |
Recruiting |
Columbia University |
2021-12-31 |
| NCT04179903 |
Efficacy and Safety of the Physical Activity Program in Women With Post-menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT04179903 |
Recruiting |
Istituto Ortopedico Rizzoli |
2020-09-15 |
| NCT04169789 |
Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri |
https://ClinicalTrials.gov/show/NCT04169789 |
Recruiting |
Sahlgrenska University Hospital, Sweden |
2022-08-31 |
| NCT04167150 |
Tart Cherry Supplementation and Women’s Bone Health Study |
https://ClinicalTrials.gov/show/NCT04167150 |
Completed |
Oklahoma State University |
2018-05-31 |
| NCT04149405 |
Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT04149405 |
Completed |
Ondokuz Mayıs University |
2017-06-30 |
| NCT04128163 |
Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk |
https://ClinicalTrials.gov/show/NCT04128163 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
2021-08-31 |
| NCT04063813 |
Parameters of Exercise to Prevent Osteoporosis |
https://ClinicalTrials.gov/show/NCT04063813 |
Completed |
University of Michigan |
2010-08-19 |
| NCT04026256 |
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration |
https://ClinicalTrials.gov/show/NCT04026256 |
Recruiting |
Massachusetts General Hospital |
2021-11-30 |
| NCT03925051 |
Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03925051 |
Active, not recruiting |
Shanghai Biomabs Pharmaceutical Co., Ltd. |
2020-03-21 |
| NCT03910348 |
Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03910348 |
Completed |
Istanbul University |
2011-05-31 |
| NCT03832088 |
Sarcopenia And Balance In Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT03832088 |
Recruiting |
Istanbul Medeniyet University |
2019-03-31 |
| NCT03832075 |
Validity of Korebalance Balance System |
https://ClinicalTrials.gov/show/NCT03832075 |
Recruiting |
Istanbul Medeniyet University |
2019-01-31 |
| NCT03761979 |
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03761979 |
Completed |
BioLink Life Sciences, Inc. |
2017-06-01 |
| NCT03742362 |
MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy Women |
https://ClinicalTrials.gov/show/NCT03742362 |
Completed |
Tel Aviv University |
2019-08-30 |
| NCT03720886 |
G56W1 in Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT03720886 |
Active, not recruiting |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
2020-05-31 |
| NCT03710889 |
Early Effects of Abaloparatide on Tissue-based Indices of Bone Formation and Resorption |
https://ClinicalTrials.gov/show/NCT03710889 |
Active, not recruiting |
Radius Health, Inc. |
2019-10-31 |
| NCT03701113 |
Milk Protein and Bone Health in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03701113 |
Recruiting |
University of Limerick |
2019-05-31 |
| NCT03623633 |
Comparative Antiresorptive Efficacy Discontinuation of Denosumab |
https://ClinicalTrials.gov/show/NCT03623633 |
Recruiting |
Massachusetts General Hospital |
2021-09-01 |
| NCT03472846 |
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT03472846 |
Active, not recruiting |
Medical University of Vienna |
2020-12-01 |
| NCT03432533 |
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis |
https://ClinicalTrials.gov/show/NCT03432533 |
Completed |
Amgen |
2019-04-11 |
| NCT01250145 |
A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT01250145 |
Completed |
Eli Lilly and Company |
2011-05-31 |
| NCT01224717 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women |
https://ClinicalTrials.gov/show/NCT01224717 |
Completed |
Novartis |
2011-04-30 |
| NCT01221727 |
The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam |
https://ClinicalTrials.gov/show/NCT01221727 |
Completed |
Amgen |
2011-07-31 |
| NCT00996801 |
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) |
https://ClinicalTrials.gov/show/NCT00996801 |
Completed |
Merck Sharp & Dohme Corp. |
2011-06-30 |
| NCT00965978 |
A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation |
https://ClinicalTrials.gov/show/NCT00965978 |
Completed |
Astellas Pharma Inc |
2009-09-30 |
| NCT00959764 |
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women |
https://ClinicalTrials.gov/show/NCT00959764 |
Completed |
Tarsa Therapeutics, Inc. |
2011-02-28 |
| NCT00936897 |
A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates |
https://ClinicalTrials.gov/show/NCT00936897 |
Completed |
Amgen |
2011-11-30 |
| NCT00927186 |
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women |
https://ClinicalTrials.gov/show/NCT00927186 |
Completed |
Eli Lilly and Company |
2010-10-31 |
| NCT00918749 |
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00918749 |
Completed |
Warner Chilcott |
2009-10-31 |
| NCT00909961 |
A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years |
https://ClinicalTrials.gov/show/NCT00909961 |
Completed |
Novartis |
2011-12-31 |
| NCT00896532 |
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density |
https://ClinicalTrials.gov/show/NCT00896532 |
Completed |
Amgen |
2011-02-21 |
| NCT00890981 |
A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab |
https://ClinicalTrials.gov/show/NCT00890981 |
Completed |
Amgen |
2010-06-30 |
| NCT00887965 |
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab |
https://ClinicalTrials.gov/show/NCT00887965 |
Completed |
Amgen |
2010-06-30 |
| NCT00860964 |
A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women |
https://ClinicalTrials.gov/show/NCT00860964 |
Completed |
Peking Union Medical College |
2003-02-28 |
| NCT02808988 |
Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT02808988 |
Completed |
Ondokuz Mayıs University |
2015-10-31 |
| NCT04064411 |
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT04064411 |
Recruiting |
Radius Health, Inc. |
2021-09-30 |
| NCT02157948 |
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT02157948 |
Completed |
Amgen |
2015-07-31 |
| NCT03816449 |
Influence of Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT03816449 |
Recruiting |
Institut za Rehabilitaciju Sokobanjska Beograd |
2019-10-30 |
| NCT00745121 |
Study Evaluating ASTRA TECH Implant System, OsseoSpeedâ„¢ Implants in the Upper Jaw in Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00745121 |
Completed |
Dentsply Sirona Implants |
2017-11-01 |
| NCT00729651 |
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) |
https://ClinicalTrials.gov/show/NCT00729651 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-10 |
| NCT00718861 |
3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs |
https://ClinicalTrials.gov/show/NCT00718861 |
Completed |
Novartis |
2013-04-30 |
| NCT00676312 |
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects |
https://ClinicalTrials.gov/show/NCT00676312 |
Completed |
Novartis |
2008-08-31 |
| NCT00674453 |
The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation |
https://ClinicalTrials.gov/show/NCT00674453 |
Completed |
Ligand Pharmaceuticals |
NA |
| NCT00670501 |
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00670501 |
Completed |
Eli Lilly and Company |
1999-04-30 |
| NCT00670319 |
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00670319 |
Completed |
Eli Lilly and Company |
1999-09-30 |
| NCT00666627 |
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects |
https://ClinicalTrials.gov/show/NCT00666627 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2012-09-30 |
| NCT00659906 |
Optimizing Body Composition & Health After Breast Cancer |
https://ClinicalTrials.gov/show/NCT00659906 |
Completed |
OHSU Knight Cancer Institute |
2009-01-31 |
| NCT00632216 |
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00632216 |
Completed |
Sanofi |
NA |
| NCT00620113 |
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) |
https://ClinicalTrials.gov/show/NCT00620113 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-29 |
| NCT00591747 |
Strength Training for Older Breast Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00591747 |
Completed |
OHSU Knight Cancer Institute |
2009-01-31 |
| NCT00578981 |
Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00578981 |
Completed |
Mayo Clinic |
2008-07-31 |
| NCT00577421 |
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO |
https://ClinicalTrials.gov/show/NCT00577421 |
Completed |
Warner Chilcott |
NA |
| NCT00567606 |
Prevention of Osteoporosis in Breast Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00567606 |
Completed |
University of Nebraska |
NA |
| NCT01232647 |
Vitamin K as Additive Treatment in Osteoporosis |
https://ClinicalTrials.gov/show/NCT01232647 |
Active, not recruiting |
Guy’s and St Thomas’ NHS Foundation Trust |
2020-03-31 |
| NCT00557310 |
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide |
https://ClinicalTrials.gov/show/NCT00557310 |
Completed |
Eli Lilly and Company |
2010-10-31 |
| NCT00551174 |
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment |
https://ClinicalTrials.gov/show/NCT00551174 |
Completed |
Hoffmann-La Roche |
2008-11-30 |
| NCT00549965 |
Satisfaction and Compliance of Risedronate in PMO |
https://ClinicalTrials.gov/show/NCT00549965 |
Completed |
Sanofi |
NA |
| NCT00549068 |
POWER Point of Care Effect on Satisfaction of Treatment |
https://ClinicalTrials.gov/show/NCT00549068 |
Completed |
Sanofi |
NA |
| NCT00545909 |
BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00545909 |
Completed |
Hoffmann-La Roche |
2008-08-31 |
| NCT00545779 |
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. |
https://ClinicalTrials.gov/show/NCT00545779 |
Completed |
Hoffmann-La Roche |
2008-10-31 |
| NCT00545480 |
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. |
https://ClinicalTrials.gov/show/NCT00545480 |
Completed |
Hoffmann-La Roche |
2009-03-31 |
| NCT00545363 |
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) |
https://ClinicalTrials.gov/show/NCT00545363 |
Completed |
Hoffmann-La Roche |
2008-01-31 |
| NCT00545090 |
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. |
https://ClinicalTrials.gov/show/NCT00545090 |
Completed |
Hoffmann-La Roche |
2008-06-30 |
| NCT00545051 |
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. |
https://ClinicalTrials.gov/show/NCT00545051 |
Completed |
Hoffmann-La Roche |
2009-05-31 |
| NCT00543218 |
PTH Comparison in Post Menopausal Women |
https://ClinicalTrials.gov/show/NCT00543218 |
Completed |
Eli Lilly and Company |
NA |
| NCT00543023 |
A Study of the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00543023 |
Completed |
Eli Lilly and Company |
NA |
| NCT00542984 |
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00542984 |
Completed |
Eli Lilly and Company |
NA |
| NCT00541658 |
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis |
https://ClinicalTrials.gov/show/NCT00541658 |
Completed |
Warner Chilcott |
2010-04-30 |
| NCT00533650 |
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) |
https://ClinicalTrials.gov/show/NCT00533650 |
Completed |
Merck Sharp & Dohme Corp. |
2002-10-31 |
| NCT00532545 |
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00532545 |
Completed |
Eli Lilly and Company |
NA |
| NCT00532428 |
Long Term Effects of Raloxifene Treatment on Bone Quality |
https://ClinicalTrials.gov/show/NCT00532428 |
Completed |
Eli Lilly and Company |
NA |
| NCT00532246 |
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo |
https://ClinicalTrials.gov/show/NCT00532246 |
Completed |
Eli Lilly and Company |
NA |
| NCT00532207 |
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00532207 |
Completed |
Eli Lilly and Company |
NA |
| NCT00503113 |
A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. |
https://ClinicalTrials.gov/show/NCT00503113 |
Completed |
Hoffmann-La Roche |
2010-04-30 |
| NCT00453492 |
Risedronate Sodium in Post Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00453492 |
Completed |
Sanofi |
NA |
| NCT00411125 |
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00411125 |
Completed |
Novartis |
NA |
| NCT00405392 |
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00405392 |
Completed |
GlaxoSmithKline |
2008-05-27 |
| NCT00402441 |
Risedronate in the Prevention of Osteoporosis in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00402441 |
Completed |
Sanofi |
2004-06-30 |
| NCT00398931 |
FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) |
https://ClinicalTrials.gov/show/NCT00398931 |
Completed |
Merck Sharp & Dohme Corp. |
2003-10-31 |
| NCT00398606 |
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00398606 |
Completed |
Merck Sharp & Dohme Corp. |
1998-02-28 |
| NCT00395395 |
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00395395 |
Completed |
Novartis |
NA |
| NCT00389740 |
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) |
https://ClinicalTrials.gov/show/NCT00389740 |
Completed |
Merck Sharp & Dohme Corp. |
2003-01-16 |
| NCT00383422 |
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00383422 |
Completed |
Eli Lilly and Company |
2008-07-31 |
| NCT00381251 |
Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. |
https://ClinicalTrials.gov/show/NCT00381251 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00377819 |
Study of Transitioning From Alendronate to Denosumab |
https://ClinicalTrials.gov/show/NCT00377819 |
Completed |
Amgen |
2008-03-31 |
| NCT00377234 |
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. |
https://ClinicalTrials.gov/show/NCT00377234 |
Completed |
Hoffmann-La Roche |
2008-08-31 |
| NCT00358176 |
Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00358176 |
Completed |
Sanofi |
2007-03-31 |
| NCT00357331 |
The Effects of Potassium Citrate on Bone Metabolism |
https://ClinicalTrials.gov/show/NCT00357331 |
Completed |
Weill Medical College of Cornell University |
2011-04-30 |
| NCT00353080 |
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00353080 |
Completed |
Sanofi |
2005-04-30 |
| NCT00351091 |
Risedronate in Postmenopausal Women With Low Bone Density |
https://ClinicalTrials.gov/show/NCT00351091 |
Completed |
Sanofi |
2003-06-30 |
| NCT00343252 |
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis |
https://ClinicalTrials.gov/show/NCT00343252 |
Completed |
Eli Lilly and Company |
2009-06-30 |
| NCT00303485 |
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) |
https://ClinicalTrials.gov/show/NCT00303485 |
Completed |
Hoffmann-La Roche |
2007-06-30 |
| NCT00293813 |
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density |
https://ClinicalTrials.gov/show/NCT00293813 |
Completed |
Amgen |
2008-03-31 |
| NCT00290212 |
Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause |
https://ClinicalTrials.gov/show/NCT00290212 |
Completed |
University Hospital of North Norway |
NA |
| NCT00271713 |
Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) |
https://ClinicalTrials.gov/show/NCT00271713 |
Completed |
Charite University, Berlin, Germany |
2007-09-30 |
| NCT00247273 |
A Study of Monthly Risedronate for Osteoporosis |
https://ClinicalTrials.gov/show/NCT00247273 |
Completed |
Warner Chilcott |
2008-03-31 |
| NCT00239629 |
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial |
https://ClinicalTrials.gov/show/NCT00239629 |
Completed |
Eli Lilly and Company |
NA |
| NCT00238745 |
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. |
https://ClinicalTrials.gov/show/NCT00238745 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00222872 |
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women |
https://ClinicalTrials.gov/show/NCT00222872 |
Completed |
University of Pittsburgh |
2008-09-30 |
| NCT00191425 |
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00191425 |
Completed |
Eli Lilly and Company |
NA |
| NCT00172107 |
A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00172107 |
Completed |
Shire |
1997-03-31 |
| NCT00172081 |
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00172081 |
Completed |
Shire |
2003-11-30 |
| NCT00168909 |
Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) |
https://ClinicalTrials.gov/show/NCT00168909 |
Completed |
Charite University, Berlin, Germany |
2007-07-31 |
| NCT00165698 |
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women |
https://ClinicalTrials.gov/show/NCT00165698 |
Completed |
Eisai Inc. |
2007-01-31 |
| NCT00165204 |
Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy |
https://ClinicalTrials.gov/show/NCT00165204 |
Completed |
Dana-Farber Cancer Institute |
2006-03-31 |
| NCT00150969 |
Vitamin K Supplementation in Post-Menopausal Osteopenia |
https://ClinicalTrials.gov/show/NCT00150969 |
Completed |
University Health Network, Toronto |
2006-09-30 |
| NCT00145977 |
Texture Analysis for Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00145977 |
Completed |
University of Chicago |
2009-12-31 |
| NCT00130403 |
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00130403 |
Completed |
Sanofi |
NA |
| NCT00092053 |
Study of Investigational Drug in Osteoporosis (MK-0217-908) |
https://ClinicalTrials.gov/show/NCT00092053 |
Completed |
Merck Sharp & Dohme Corp. |
2005-07-31 |
| NCT00092040 |
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) |
https://ClinicalTrials.gov/show/NCT00092040 |
Completed |
Merck Sharp & Dohme Corp. |
2004-10-18 |
| NCT00092027 |
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) |
https://ClinicalTrials.gov/show/NCT00092027 |
Completed |
Merck Sharp & Dohme Corp. |
2004-03-15 |
| NCT00092014 |
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) |
https://ClinicalTrials.gov/show/NCT00092014 |
Completed |
Merck Sharp & Dohme Corp. |
2004-04-01 |
| NCT00091793 |
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00091793 |
Completed |
Amgen |
2009-02-28 |
| NCT00088010 |
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer |
https://ClinicalTrials.gov/show/NCT00088010 |
Completed |
Eli Lilly and Company |
2009-06-30 |
| NCT00086619 |
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00086619 |
Completed |
Massachusetts General Hospital |
2009-12-31 |
| NCT00085956 |
Effects of Arzoxifene on Bone Mass and the Uterus |
https://ClinicalTrials.gov/show/NCT00085956 |
Completed |
Eli Lilly and Company |
NA |
| NCT00081653 |
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva |
https://ClinicalTrials.gov/show/NCT00081653 |
Completed |
Hoffmann-La Roche |
2007-11-30 |
| NCT00079924 |
Effects of Teriparatide in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00079924 |
Completed |
Eli Lilly and Company |
NA |
| NCT00073190 |
Patient- and Physician-Based Osteoporosis Education |
https://ClinicalTrials.gov/show/NCT00073190 |
Completed |
Brigham and Women’s Hospital |
2006-06-30 |
| NCT00010712 |
Effects of Black Cohosh on Menopausal Hot Flashes |
https://ClinicalTrials.gov/show/NCT00010712 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00048074 |
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00048074 |
Completed |
Hoffmann-La Roche |
2005-05-31 |
| NCT00048061 |
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis |
https://ClinicalTrials.gov/show/NCT00048061 |
Completed |
Hoffmann-La Roche |
2004-12-31 |
| NCT00046137 |
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00046137 |
Completed |
Eli Lilly and Company |
NA |
| NCT00035256 |
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis |
https://ClinicalTrials.gov/show/NCT00035256 |
Completed |
Eli Lilly and Company |
NA |
| NCT00018447 |
Combination Osteogenic Therapy in Established Osteoporosis |
https://ClinicalTrials.gov/show/NCT00018447 |
Completed |
VA Office of Research and Development |
NA |